Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Gastroenterology

• Publication date

  2013-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.gastro.2013.06.052PMID 23827861PMCID PMC3815445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14.

  2013cited by this paper
• Inflammatory Bowel Disease in Primary Sclerosing Cholangitis: A Robust yet Changing Relationship

  2013cited by this paper
• Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis

  2013cited by this paper
• The fate of indefinite and low‐grade dysplasia in ulcerative colitis and primary sclerosing cholangitis colitis before and after liver transplantation

  2013cited by this paper
• Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

  2013cited by this paper
• Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis.

  2013cited by this paper
• Circulating CD4+CD25+ Regulatory T Cells in the Pathobiology of Ulcerative Colitis and Concurrent Primary Sclerosing Cholangitis

  2013cited by this paper
• Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis

  2013cited by this paper
• Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study

  2012cited by this paper
• The many faces of Janus kinase.

  2012cited by this paper
• Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

  2012cited by this paper
• Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis.

  2012influential reference
• Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease

  2012cited by this paper
• Review article: overlap syndromes and autoimmune liver disease

  2012cited by this paper
• Risk factors for complications of ERCP in primary sclerosing cholangitis

  2012cited by this paper
• Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action.

  2012cited by this paper
• Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders

  2012cited by this paper
• Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.

  2012influential reference
• Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis.

  2012influential reference
• Inflammatory bowel disease in patients with primary sclerosing cholangitis: Clinical characterization in liver transplanted and nontransplanted patients

  2012cited by this paper
• Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose‐ranging Study

  2012cited by this paper
• Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)

  2012cited by this paper
• Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012

  2012cited by this paper
• High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

  2012cited by this paper
• Likelihood of Malignancy in Gallbladder Polyps and Outcomes Following Cholecystectomy in Primary Sclerosing Cholangitis

  2012cited by this paper
• Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long‐term single‐centre study

  2012cited by this paper
• Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.

  2012cited by this paper
• Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis

  2011cited by this paper
• Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?

  2011cited by this paper
• Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct–ligated rats and human hepatic cells

  2011cited by this paper
• Cancer surveillance in patients with primary sclerosing cholangitis

  2011influential reference
• Meta‐analysis: ursodeoxycholic acid for primary sclerosing cholangitis

  2011cited by this paper
• Pregnancy in primary sclerosing cholangitis

  2011cited by this paper
• Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis.

  2011cited by this paper
• What's Hot in the Red Journal This Month

  2011cited by this paper
• Farnesoid X receptor agonists for primary biliary cirrhosis

  2011cited by this paper
• Will we ever model PSC? - "it's hard to be a PSC model!".

  2011cited by this paper
• AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Incidence of Primary Sclerosing Cholangitis: a Systematic Review and Meta-Analysis

  2011influential reference
• High‐dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

  2011cited by this paper
• A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures

  2011cited by this paper
• Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis

  2011cited by this paper
• Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis.

  2011cited by this paper
• Current Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangitis

  2011cited by this paper
• Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity

  2011cited by this paper
• Primary Sclerosing Cholangitis Patients With Serial Polysomy Fluorescence In Situ Hybridization Results Are at Increased Risk of Cholangiocarcinoma

  2011cited by this paper
• Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

  2011cited by this paper
• Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue.

  2011cited by this paper
• Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4‐associated cholangitis from cholangiocarcinoma

  2011cited by this paper
• Pathogenesis of primary sclerosing cholangitis

  2011cited by this paper
• Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)

  2011cited by this paper
• Comorbidities, Sphincterotomy, and Balloon Dilation Predict Post-ERCP Adverse Events in PSC Patients: Operator Experience Is Protective

  2011cited by this paper
• Primary Sclerosing Cholangitis Associated with Elevated ImmunoglobulinG4: Clinical Characteristics and Response to Therapy

  2011cited by this paper
• Increased Risk of Colorectal Cancer and Dysplasia in Patients With Crohn's Colitis and Primary Sclerosing Cholangitis

  2011influential reference
• Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography.

  2010cited by this paper
• Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)

  2010cited by this paper
• AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

  2010cited by this paper
• Diagnosis and management of primary sclerosing cholangitis

  2010influential reference
• IgG4+ Plasma Cell Infiltrates in Liver Explants With Primary Sclerosing Cholangitis

  2010cited by this paper
• Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis.

  2010cited by this paper
• Genome-wide association analysis in primary sclerosing cholangitis.

  2010cited by this paper
• Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis

  2010cited by this paper
• Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden

  2010cited by this paper
• p-ANCAs in autoimmune liver disorders recognise human β-tubulin isotype 5 and cross-react with microbial protein FtsZ

  2009cited by this paper
• Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells.

  2009cited by this paper
• EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

  2009cited by this paper
• IL-17 and Th17 Cells.

  2009cited by this paper
• The immunobiology of primary sclerosing cholangitis

  2009influential reference
• Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation

  2009cited by this paper
• Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis

  2009influential reference
• Atypical p-ANCA in PSC and AIH: A Hint Toward a “leaky gut”?

  2009cited by this paper
• AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Long-Term Outcomes of Positive Fluorescence In Situ Hybridization Tests in Primary Sclerosing Cholangitis

  2009influential reference
• Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice

  2009cited by this paper
• Pathologic Features of Ulcerative Colitis in Patients With Primary Sclerosing Cholangitis: A Case-control Study

  2009cited by this paper
• Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study

  2009cited by this paper
• Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies

  2009cited by this paper
• High‐dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

  2009cited by this paper
• Pathogenesis of primary sclerosing cholangitis.

  2008cited by this paper
• Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: Evaluating the role of routine magnetic resonance imaging

  2008cited by this paper
• The natural history of small-duct primary sclerosing cholangitis.

  2008cited by this paper
• Etiopathogenesis of primary sclerosing cholangitis.

  2008cited by this paper
• Current and future anti-fibrotic therapies for chronic liver disease.

  2008cited by this paper
• Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease

  2008cited by this paper
• Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.

  2008cited by this paper
• Gallbladder disease in patients with primary sclerosing cholangitis.

  2008cited by this paper
• A Double-blind, Placebo-controlled, Randomized Study of Infliximab in Primary Sclerosing Cholangitis

  2008cited by this paper
• Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long‐term outcome and survival

  2008cited by this paper
• High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

  2007cited by this paper
• Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.

  2007cited by this paper
• Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein)

  2007cited by this paper
• MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes.

  2007cited by this paper
• Immunoglobulin G4 associated cholangitis: Description of an emerging clinical entity based on review of the literature

  2007cited by this paper
• Incidence, Diagnosis, and Therapy of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis

  2007cited by this paper
• The Burden of Large and Small Duct Primary Sclerosing Cholangitis in Adults and Children: A Population-Based Analysis

  2007cited by this paper
• Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism.

  2007cited by this paper
• Liver transplantation in primary sclerosing cholangitis.

  2006cited by this paper
• Invited review: Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease

  2006cited by this paper
• Etiopathogenesis of primary sclerosing cholangitis.

  2006cited by this paper
• Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC

  2006cited by this paper
• The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis

  2006cited by this paper
• Inflammatory Bowel Disease After Liver Transplantation: Risk Factors for Recurrence and De Novo Disease

  2006cited by this paper

• Decoding the Role of H19 in Cholestatic Liver Injury Using snRNA-seq, Spatial Transcriptomics, and Machine Learning-Based Disease Prediction

  2026cites this paper
• Management of Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis Pre- and Post-liver Transplantation.

  2026cites this paper
• Clinical Outcomes in Patients with Primary Sclerosing Cholangitis With and Without Inflammatory Bowel Disease.

  2026cites this paper
• Genetic ablation of interleukin-17A augments fibrosis in a mouse model of cholestatic liver injury

  2026cites this paper
• Long-term clinical and endoscopic outcomes of ulcerative colitis after liver transplantation: a multicenter cohort study on the use and safety of advanced therapies.

  2026cites this paper
• Liver diseases: epidemiology, causes, trends and predictions

  2025cites this paper
• Deep learning analysis of magnetic resonance imaging accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis.

  2025cites this paper
• Cholecystectomy Is Linked to Worse Clinical Outcomes in Primary Sclerosing Cholangitis

  2025cites this paper
• Global burden of gallbladder and biliary diseases (1990–2021) with healthcare workforce analysis and projections to 2035

  2025cites this paper
• Prevalence and Bidirectional Association Between Primary Sclerosing Cholangitis and Crohn's disease: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Comparative Analysis of FUT1 and FUT2 Haplotype Diversity in Multi‐Ethnic Populations Via Long‐Read Sequencing

  2025cites this paper
• SPANISH CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF CHOLESTATIC LIVER DISEASES IN ADULT AND PEDIATRIC POPULATION: JOINT REPORT FROM AEEH AND SEGHNP.

  2025cites this paper
• Performance of the Mayo Risk Score in Predicting Transplant and Mortality in a Single-Center U.S. Cohort of Primary Sclerosing Cholangitis

  2025cites this paper
• The 2024 diagnostic criteria for primary sclerosing cholangitis

  2025cites this paper
• Exploring the Role of MRCP+ for Enhancing Detection of High-Grade Strictures in Primary Sclerosing Cholangitis

  2025cites this paper
• A multi-mineral intervention to improve disease-related and mechanistic biomarkers in ulcerative colitis patients: Results from a randomized trial

  2025cites this paper
• Autoimmune liver diseases and systemic rheumatic disorders: exploring their interplay and impact on prognosis

  2025cites this paper
• Correlation Between Rumination, Symptom Clusters, and Quality of Life in Patients With Inflammatory Bowel Disease

  2025cites this paper
• Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets

  2025cites this paper
• Liver Cirrhosis: Contemporary Insights into Pathogenesis, Evidence-Based Management, and Emerging Therapeutic Strategies

  2025cites this paper
• Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females

  2025cites this paper
• A MULTI-MINERAL INTERVENTION TO IMPROVE DISEASE-RELATED AND MECHANISTIC BIOMARKERS IN ULCERATIVE COLITIS PATIENTS

  2025cites this paper
• Enhanced Virulence and Pro-Inflammatory Potential of Bile-Derived Escherichia coli and Klebsiella pneumoniae Isolates in Primary Sclerosing Cholangitis: Implications for Disease Pathogenesis.

  2025cites this paper
• Emerging Targets for the Treatment of Primary Sclerosing Cholangitis

  2025cites this paper
• Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.

  2025cites this paper
• MSC-derived exosomes attenuate hepatic fibrosis in primary sclerosing cholangitis through inhibition of Th17 differentiation

  2024cites this paper
• Causal associations between gut microbiota and Cholestatic liver diseases: a Mendelian randomization study

  2024cites this paper
• Dietary Habits of Individuals With Primary Sclerosing Cholangitis—Poor Fat‐Soluble Vitamin Intake and Dietary Quality

  2024cites this paper
• Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments

  2024cites this paper
• Berberine ameliorates the progression of primary sclerosing cholangitis by activating farnesoid X receptor

  2024cites this paper
• The mediating role of primary sclerosing cholangitis in the association between ulcerative colitis and hepatobiliary cancer investigated through Mendelian randomization

  2024cites this paper
• Deep Learning–Based Prediction of Hepatic Decompensation in Patients With Primary Sclerosing Cholangitis With Computed Tomography

  2024cites this paper
• Untangling biliary reconstruction in liver transplants for primary sclerosing cholangitis.

  2024cites this paper
• Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship.

  2024cites this paper
• Transplantation Within 6 Months of Registration does not Enhance Survival for Patients with Perihilar Cholangiocarcinoma.

  2024cites this paper
• Phospholipid complex-based microemulsion for treating concurrence of primary sclerosing cholangitis and inflammatory bowel disease via gut-liver crosstalk

  2024cites this paper
• Astragali radix (Huangqi): a time-honored nourishing herbal medicine

  2024cites this paper
• Computed tomography-based radiomics and body composition model for predicting hepatic decompensation

  2024cites this paper
• The State of Systematic Therapies in Clinic for Hepatobiliary Cancers

  2024cites this paper
• Therapeutic potential of berberine in attenuating cholestatic liver injury: insights from a PSC mouse model

  2024cites this paper
• Liver transplantation for primary sclerosing cholangitis—morbidities including disease recurrence

  2024cites this paper
• Multiomic Sequencing Reveals Distinctive Gene Expression and Epigenetic Alterations Associated With Primary Sclerosing Cholangitis Development in Treatment-Naïve Pediatric Ulcerative Colitis

  2024cites this paper
• Leveraging pQTL-based Mendelian randomization to identify new treatment prospects for primary biliary cholangitis and primary sclerosing cholangitis

  2024cites this paper
• Liver fibrosis pathologies and potentials of RNA based therapeutics modalities

  2024cites this paper
• CYP2E1 deficit mediates cholic acid-induced malignant growth in hepatocellular carcinoma cells

  2024cites this paper
• Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data

  2024cites this paper
• Mimickers of immunoglobulin G4-related hepatobiliary disease on biopsy.

  2024cites this paper
• Research Progress of Fecal Microbiota Transplantation in Liver Diseases

  2023cites this paper
• Beta-lapachone ameliorates the progression of primary sclerosing cholangitis pathogenesis in rodent models.

  2023cites this paper
• Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications.

  2023cites this paper
• Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets

  2023cites this paper
• Primary Squamous Cell Biliary Carcinoma With Liver Metastasis Is Rare but Malicious

  2023cites this paper
• Primary sclerosing cholangitis hospitalizations in the United States: characteristics and predictors of clinical outcomes

  2023cites this paper
• NK cell marker gene-based model shows good predictive ability in prognosis and response to immunotherapies in hepatocellular carcinoma

  2023cites this paper
• Averting an Unnecessary Revision of a Roux-en-Y Hepaticojejunostomy by Surgically Creating an Access Point for the Endoscopic Assessment of the Anastomosis: A Report of a Case

  2023influential citation
• Imaging of the biliary tract

  2023cites this paper
• Global burden of Liver Disease: 2023 Update.

  2023cites this paper
• Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis

  2023cites this paper
• Longitudinal analysis of transplant candidates with primary sclerosing cholangitis in an Asian liver transplant center

  2023cites this paper
• Interplay between Mast Cells and Regulatory T Cells in Immune-Mediated Cholangiopathies

  2022cites this paper
• Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis

  2022cites this paper
• Case Report: What—or who—killed Frank Ramsey? Some reflections on cause of death and the nature of medical reasoning

  2022cites this paper
• Serological biomarkers for management of primary sclerosing cholangitis

  2022cites this paper
• Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis

  2022cites this paper
• Comparative Performance of Quantitative and Qualitative Magnetic Resonance Imaging Metrics in Primary Sclerosing Cholangitis

  2022cites this paper
• Assessment of Three-Phasic CT Scan Findings of Cirrhosis Due to Primary Sclerosing Cholangitis Versus Cryptogenic Cirrhosis

  2022cites this paper
• Identification and clinical significance of nodular regenerative hyperplasia in primary sclerosing cholangitis

  2022cites this paper
• Hierarchy‐Assembled Dual Probiotics System Ameliorates Cholestatic Drug‐Induced Liver Injury via Gut‐Liver Axis Modulation

  2022cites this paper
• MR elastography in primary sclerosing cholangitis: a pictorial review

  2022cites this paper
• Primary Sclerosing Cholangitis Complicated with Aphthoid Colitis Difficult to Diagnose from IgG4-Related Sclerosing Cholangitis

  2022cites this paper
• Changes in beta-catenin expression and activation during progression of primary sclerosing cholangitis predict disease recurrence

  2022cites this paper
• An update on novel pharmacological agents for primary sclerosing cholangitis

  2022cites this paper
• Changes of Serum Cytokine Levels and Relation to Clinical Specificity in Patients with Primary Biliary Cholangitis

  2022cites this paper
• Cáncer de vesícula biliar, una visión actual

  2022cites this paper
• Changes of Serum Cytokine Levels and Relation to Clinical Specificity in Patients with Primary Biliary Cholangitis

  2022cites this paper
• The autophagic protein p62 is a target of reactive aldehydes in human and murine cholestatic liver disease

  2022cites this paper
• Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: A role for IL‐17A

  2022cites this paper
• Algebraic topology-based machine learning using MRI predicts outcomes in primary sclerosing cholangitis

  2022cites this paper
• Etiopathogenesis and pathophysiology of cholestasis

  2022cites this paper
• Research progress of single-cell transcriptome sequencing in autoimmune diseases and autoinflammatory disease: A review.

  2022cites this paper
• Etiopathogenesis and pathophysiology of cholestasis Exploration of Digestive Diseases

  2022cites this paper
• Current trends and future perspectives in the treatment of PBC and PSC: A review

  2022cites this paper
• Increased concentrations of conjugated bile acids are associated with osteoporosis in PSC patients

  2022cites this paper
• Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice.

  2022cites this paper
• Decreased CD57 expression of natural killer cells enhanced cytotoxicity in patients with primary sclerosing cholangitis

  2022influential citation
• Aberrant peribiliary gland niche exacerbates fibrosis in primary sclerosing cholangitis and a potential therapeutic strategy.

  2022cites this paper
• Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis

  2022cites this paper
• Small duct primary sclerosing cholangitis: A discrete variant or a bridge to large duct disease, a practical review

  2022cites this paper
• Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis

  2022cites this paper
• Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study

  2022cites this paper
• Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis

  2021influential citation
• Cutting edge issues in juvenile sclerosing cholangitis.

  2021cites this paper
• Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group

  2021cites this paper
• The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies

  2021cites this paper
• Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017

  2021cites this paper
• Modulation of the Mucosa-Associated Microbiome Linked to the PTPN2 Risk Gene in Patients with Primary Sclerosing Cholangitis and Ulcerative Colitis

  2021cites this paper
• Chronic recurrent multifocal osteomyelitis and primary sclerosing cholangitis with type 1 autoimmune hepatitis in a child with ulcerative colitis: a case report

  2021cites this paper
• Intra-Hepatic Cholestasis of Pregnancy and Its Consequences: A Review

  2021cites this paper
• Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents

  2021cites this paper
• Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis vs. viral hepatitis assessed by MR elastography

  2021cites this paper